Sensei Biotherapeutics, Inc.
About
Sensei Biotherapeutics, Inc. is a clinical-stage biotechnology company focused on developing and discovering next-generation cancer therapeutics. The company utilizes its proprietary biologics platform to create treatments that selectively target the tumor microenvironment. Its primary goal is to advance its pipeline candidates through clinical trials and eventually commercialize them to treat various forms of cancer.
Company Values
The company's competitive advantage lies in its proprietary Tumor Microenvironment Activated Biologics (TMAB) platform. This platform is designed to generate therapeutics that can selectively disable immunosuppressive signals or activate immunostimulatory signals directly within the tumor, potentially improving efficacy and reducing side effects.